SoftBank, TelevisaUnivision and NielsenIQ helped provide the customer loyalty app developer with fresh capital in a round more than doubling its valuation to $2.5bn.

China Life Private Equity Investment and PICC Capital returned to co-lead the pharmaceutical discovery technology provider’s latest rounds, four months after it emerged from stealth.

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Mitsui took part in oncology therapy developer Ensem Therapeutics' $67m series A round while Bioventus is paying up to $450m to buy the rest of portfolio company CartiHeal.

The sports gear retailer has disclosed its largest round was led by the NFL and included the MLB, NHL and Paris Saint-Germain, at a $27bn valuation.

FTX Ventures took part in the cryptocurrency protocol developer’s latest round, which followed a $150m token sale three months ago.

The drug retailer’s AB Health Ventures unit will focus on early to mid-stage healthcare technology providers working on areas including pharmaceutical distribution, commercialisation and pet care.

The Stripe-backed rapid checkout tool developer was valued at $1bn early last year but is closing its doors after failing to raise more cash.

SoftBank Vision Fund 2 led the healthcare management software provider’s series D round, taking its overall funding to about $213m and its valuation to a reported $1.4bn.

The company, which largely remains in stealth mode, has set itself a mission of increasing the human lifespan by a decade.